Dana Investment Advisors’s Acceleron Pharma XLRN Stock Holding History

Dana Investment Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,160	Closed	-$716K	–	354
2021 Q3	$716K	Buy	4,160 +227	+6%	+$29.7K	0.03%	227
2021 Q2	$494K	Buy	+3,933	New	+$496K	0.02%	253

Dana Investment Advisors's XLRN Position: Q4 2021 in Review

Dana Investment Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 4,160 shares — an estimated $716K sold.

Dana Investment Advisors first reported a position in XLRN in Q2 2021 and held it in 2 quarters. The position peaked at $716K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Dana Investment Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Dana Investment Advisors sold 4,160 Acceleron Pharma shares in Q4 2021, an estimated $716K.
Dana Investment Advisors first reported a position in Acceleron Pharma in Q2 2021 and held it in 2 quarters.
Dana Investment Advisors's Acceleron Pharma position peaked at $716K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Dana Investment Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.